SlideShare a Scribd company logo
HIGH RISK PREGNANCY
COMPLICATIONS OF CHILDBIRTH
DR. MITALI SRIVASTAVA, MBBS, MD,
SEXUAL MEDICINE CONSULTANT,
SHITAL WOMENS HOSPITAL, AHMEDABAD,
the.besharam.doctor
HIGH RISK PREGNANCY [HRP]
 Refers to pregnancies in which the mother or the fetus
has an increased risk of complications compared to
uncomplicated pregnancies
 Maternal and medical risks increase pregnancy risk and
complications during pregnancy and childbirth
BAD OBSTETRIC HISTORY
 1st or 2nd trimester miscarriages
 Still birth
 Small weight baby
 Fetal anomalies
 IUGR- intrauterine growth restriction
 Prolonged labor
 Massive PPH
 IUD- intrauterine death
 Recurrent pregnancy loss
HEART DISEASE
SEVERE ANEMIA
Who is at risk?
• Have two closely spaced pregnancies
• Are pregnant with more than one baby
• Are vomiting frequently due to morning sickness
• Don't consume enough iron-rich foods
• Have a heavy pre-pregnancy menstrual flow
• Have a history of anemia before your pregnancy
SEVERE ANEMIA
What are the signs and symptoms?
 Anemia:
• Fatigue
• Weakness
• Dizziness or lightheadedness
• Headache
• Pale or yellowish skin
• Shortness of breath
• Craving or chewing ice (pica)
 Severe anemia:
• A rapid heartbeat
• Low blood pressure
• Difficulty concentrating
SEVERE ANEMIA
Prevention:
 Iron RDA (required daily allowance): 30mg/day
 Iron rich diet
 Iron supplements:
 Should be taken with vit C (helps absorption)
 Should not be taken with calcium (reduces absorption)
 Can cause constipation, gastric disturbances, dark stools
SEVERE ANEMIA
Treatment:
 Iron injections (eg. Revofer, IV iron bolus)
 Blood transfusions, Packed cell volume transfusions
MULTIPLE PREGNANCY
Why is it high risk?
 Preterm labor and birth
 Gestational hypertension
 Anemia
 Birth defects
 Miscarriage
 Postpartum hemorrhage
 Twin to twin transfusion syndrome
 Lower backache/ disc prolapse
PRE-ECLAMPSIA & ECLAMPSIA
 Preeclampsia is a pregnancy-specific disorder involving
 Widespread endothelial dysfunction and vasospasm
 Occurs after 20 weeks of gestation and can present as late as 4-6
weeks postpartum
 Clinically defined by new-onset hypertension and proteinuria, with
or without severe features
 In a previously normotensive patient: >140/90 mmHg, measured atleast
twice, 4 hrs apart
 Or a one time reading >160/110 mmHg
PRE-ECLAMPSIA & ECLAMPSIA
 Severe features:
• Impaired hepatic function (elevated LFT)
• Severe persistent upper quadrant or epigastric pain that does not respond to
pharmacotherapy and is not accounted for by alternative diagnoses
• Progressive renal insufficiency
• (serum creatinine concentration >1.1 mg/dL or a doubling of the serum
creatinine concentration in the absence of other renal disease)
• New-onset cerebral or visual disturbances
• Pulmonary edema
• Thrombocytopenia
PRE-ECLAMPSIA & ECLAMPSIA
Who is at risk?
• Nulliparity
• Multifetal gestations
• Preeclampsia in a previous pregnancy
• Chronic hypertension
• Pregestational diabetes
• Gestational diabetes
• Thrombophilia
• Systemic Lupus Erythematoses [SLE]
• Pre-pregnancy BMI >30
• Antiphospholipid antibody syndrome
• Maternal age 35 years or older
• Kidney disease
• ART: IVF etc
PRE-ECLAMPSIA & ECLAMPSIA
What are the clinical features?
• Headache
• Visual disturbances: Blurred, scintillating scotomata
• Altered mental status
• Blindness: May be cortical [3] or retinal
• Dyspnea
• Edema: Sudden increase in edema or facial edema
• Epigastric or right upper quadrant abdominal pain
• Weakness or malaise: May be evidence of hemolytic anemia
• Clonus: May indicate an increased risk of convulsions
PRE-ECLAMPSIA & ECLAMPSIA
 HELLP syndrome
 Hemolysis
 Elevated liver enzymes
 Low platelets
PRE-ECLAMPSIA & ECLAMPSIA
 Management of Pre-eclampsia & eclampsia:
 Delivery is the only cure for preeclampsia
 Patients with preeclampsia without severe features induced after 37 weeks
 <37 weeks Hospitalized and monitored for development of worsening
preeclampsia or complications of preeclampsia
 Immature fetus is treated with corticosteroids to accelerate lung maturity in
preparation for early delivery
PRE-ECLAMPSIA & ECLAMPSIA
Management of active seizures:
 The basic principles of airway, breathing, and circulation (ABC) should always be
followed
 Magnesium sulfate is the first-line treatment for primary and recurrent
eclamptic seizures
 A loading dose of 4-6g is given by infusion pump over 5-10 minutes
 Followed by maintenance dose: infusion of 1g/hr maintained for 24 hours after
the last seizure
PRE-ECLAMPSIA & ECLAMPSIA
 Recurrent seizures: Treated with an additional bolus of 2 g or an
increase in the infusion rate to 1.5 or 2 g/hr
 Prophylactic treatment with magnesium sulfate is indicated for all
patients with preeclampsia with severe features
 Magnesium sulfate is discontinued 24 hrs after delivery
 Lorazepam and phenytoin may be used as second-line agents for
refractory seizures
PRE-ECLAMPSIA & ECLAMPSIA
Acute treatment of severe hypertension in pregnancy
 Antihypertensive treatment is recommended for severe hypertension (>160/110 mmHg)
 Goal of hypertension treatment: 140/90 mm Hg
 Medications used for BP control include the following:
• Hydralazine
• Labetalol
• Nifedipine
• Sodium nitroprusside (in severe hypertensive emergency refractory to other
medications)
PRE-ECLAMPSIA & ECLAMPSIA
Fluid management
• Diuretics should be avoided
• Aggressive volume resuscitation may lead to pulmonary edema
• Patients should be fluid restricted when possible, at least until the period of
postpartum diuresis
• Central venous pressure (CVP) or pulmonary artery pressure monitoring may be
indicated in critical cases
• A CVP of 5 mm Hg in women with no heart disease indicates sufficient
intravascular volume, and maintenance fluids alone are sufficient
• Total fluids should generally be limited to 80 mL/hr or 1 mL/kg/hr
PRE-ECLAMPSIA & ECLAMPSIA
Postpartum management
• Many patients will have a brief (up to 6 hours) period of oliguria following delivery
• Magnesium sulfate seizure prophylaxis is continued for 24 hours postpartum
• LFT and platelet counts must document decreasing values prior to hospital discharge
• Elevated BP may be controlled with nifedipine or labetalol postpartum
• If discharged with BP medication, reassessment and a BP check should be performed,
frequently and followed up with physician for further management
• In most cases of preeclampsia, the BP returns to baseline by 12 weeks postpartum
• Patients should be carefully monitored for recurrent preeclampsia, which may develop up
to 4 weeks postpartum, and for eclampsia that has occurred up to 6 weeks after delivery
GESTATIONAL DIABETES
 Defined as glucose intolerance of variable degree with onset or first
recognition during pregnancy
 Infants of mothers with preexisting DM experience
 double the risk of serious injury at birth
 triple the likelihood of LSCS
 quadruple the incidence of NICU admission
 GDM: 90% of cases of diabetes mellitus in pregnancy
 Pre- existing type 2 diabetes accounts for 8%
GESTATIONAL DIABETES
 Screening for GDM:
 Random blood sugar as a part of routine reports
 OGTT by 5th month of pregnancy
 Diagnosis:
 Fasting blood glucose
 Post-prandial blood glucose
 HbA1c
GESTATIONAL DIABETES
 Management:
 Diet care
 Glyburide & metformin
 Insulin
 Prenatal obstetric Mx:
 Doppler studies
 Fetal heart rate and movement
 Mx of Neonate:
 Frequent blood glucose checks
 Early oral feeding
ABRUPTIO PLACENTAE/ PLACENTAL ABRUPTION
Separation of placenta,
partially or totally,
from its implantation site,
before delivery
 Consumptive
coagulopathy
 Very high risk of IUD
 Fluid replacement with
5% hydroxyethyl
starch (plasma volume
substitute)
 LSCS
ABRUPTIO PLACENTAE/ PLACENTAL ABRUPTION
PLACENTA PREVIA Previa: (Latin) ‘before’ the fetus
Placental migration
PLACENTA PREVIA
 Painless bleeding, bouts of
frequent bleeding
 Dx: USG
 Mx:
 Tocolytics
 Progesterone
supplementation
 Tranexa
 Absolute bed rest
 Planned CS
 Emergency delivery if
bleeding is not
controlled
PLACENT PREVIA
 Especially in acreta spectrum
 Incision is placed in the upper segment, above the tentative position of
placenta.
 Baby delivered first
 Placenta is allowed to separate naturally if possible
 Uterine artery or internal iliac artery ligation helpful
 High risk for hysterectomy, ICU outcome, Blood transfusion
CERVICAL INCOMPETENCE
 N- wiring/ cervical
cerclage
 14 to 16 weeks: preventive
 Or as detected
THREATENED PRETERM LABOR
 At risk for preterm delivery (<37 weeks)
 Mx aimed towards stopping labor if possible
 Or delaying labor till effect of corticosteroids occurs to bring fetal lungs to
maturity
 If labor progresses, to conduct a safe delivery
OTHER CONDITIONS IN HIGH RISK PREGNANCY
 Thrombocytopenia or megaloblastic anemia and other bleeding disorders
 Thalassemia
 History of thrombosis or thrombophilias
 History of neurological disease (epilepsy, brain haemorrhage, or tumor)
 Malignancy (cervical, ovarian or breast)
 Fibroid uterus
 Congenital malformations that can survive
COMPLICATIONS IN CHILDBIRTH
 DYSTOCIA
 PROM
 PRECIPITATE LABOR
 ABNORMAL PRESENTATIONS
 UMBILICAL CORD PROLAPSE
 PPH
 AMNIOTIC FLUID EMBOLISM
DYSTOCIA
• Difficult, prolonged labor
• Abnormally slow labor
progress
• Non- progression of labor
[NPL]
• Pathology lies with:
• P- power
• P- passenger
• P- passage
PROM- PREMATURE RUPTURE OF MEMBRANES
 Membrane rupture at term without spontaneous uterine contractions
 Wait for 6 hrs, and if labor still doesn’t start, induction of labor
 Prostaglandin E2 gel (Cerviprime)
 Oxytocin infusion IV, after labor initiates only
 Antibiotic coverage
 Increased risk of:
 Chorioamnionitis
 NICU admission
PRECIPITATE LABOR
 Abnormal extremely rapid labor and delivery
 Expulsion of fetus in <3 hrs from initiation of labor
 Less complications if cervix is effaced
 Otherwise:
 Cervical/ vaginal/ vulval tears/ lacerations
 Uterine rupture
 Amniotic fluid embolism
 PPH
 Linked with cocaine abuse
 Newborn injury risk
ABNORMAL PRESENTATIONS IN VAGINAL
DELIVERY
Transverse lie
External cephalic version
UMBILICAL CORD PROLAPSE
 Can occur during labor, or be a presenting part
 Eventually causes cord compression
 Risk factors:
 High floating head
 Polyhydramnios
 Abnormal presentations
 Very small baby
 Multifetal gestations
 Mx: Head up, manual elevation of fetal head, lscs
PPH- POST PARTUM HEMORRHAGE
PPH- POST PARTUM HEMORRHAGE
 Investigation:
 Labs: Hb, Hematocrit evaluation to watch for blood loss
 USG: To look for retained placental products
 Management:
 Uterine massage
 Fluid replacement
 oxytocin
 Tranexa
 Methergine
 Misoprostol etc
 Surgical management
 Surgical management:
 Vaginal and cervical laceration for traumatic PPH
 Laprotomy
 Uterine rupture
 Uterine lacerations
 Hematoma
 Uterine artery or internal iliac artery ligation
 Compression sutures
 Uterine packing (removed after 24 hrs)
 Cath lab: Angiographic embolization of uterine artery
B- Lynch sutures
RARE COMPLICATIONS
 Uterine inversion
 Amniotic fluid embolism
 Uterine rupture
 Retained placenta
 Puerperial sepsis

More Related Content

Similar to 4 High risk preganancy and complications of child birth.pptx

HYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptxHYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptx
HannatAboud
 
highriskpregnancy-190711111446.pdf
highriskpregnancy-190711111446.pdfhighriskpregnancy-190711111446.pdf
highriskpregnancy-190711111446.pdf
ahmedkhan266631
 
Pre-Eclampsia and Hypertensive Disease in Pregnancy
Pre-Eclampsia and Hypertensive Disease in PregnancyPre-Eclampsia and Hypertensive Disease in Pregnancy
Pre-Eclampsia and Hypertensive Disease in Pregnancy
meducationdotnet
 
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptx
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptxNATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptx
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptx
okakadaniel
 
highriskpregnancy-190711111446 (1).pptx
highriskpregnancy-190711111446 (1).pptxhighriskpregnancy-190711111446 (1).pptx
highriskpregnancy-190711111446 (1).pptx
Subi Babu
 

Similar to 4 High risk preganancy and complications of child birth.pptx (20)

Hypertention in pregnancy
Hypertention in pregnancy Hypertention in pregnancy
Hypertention in pregnancy
 
HYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptxHYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptx
 
HYPERTENSION IN PREGNANCY SOGON FINAL ONE.ppt
HYPERTENSION IN PREGNANCY SOGON FINAL ONE.pptHYPERTENSION IN PREGNANCY SOGON FINAL ONE.ppt
HYPERTENSION IN PREGNANCY SOGON FINAL ONE.ppt
 
High risk pregnancy
High risk pregnancyHigh risk pregnancy
High risk pregnancy
 
highriskpregnancy-190711111446.pdf
highriskpregnancy-190711111446.pdfhighriskpregnancy-190711111446.pdf
highriskpregnancy-190711111446.pdf
 
Pre-Eclampsia and Hypertensive Disease in Pregnancy
Pre-Eclampsia and Hypertensive Disease in PregnancyPre-Eclampsia and Hypertensive Disease in Pregnancy
Pre-Eclampsia and Hypertensive Disease in Pregnancy
 
Pregnancy induced hypertension
Pregnancy induced hypertensionPregnancy induced hypertension
Pregnancy induced hypertension
 
Management of Pre-eclampsia and eclampsia Case discussions
Management of Pre-eclampsiaand eclampsia Case discussionsManagement of Pre-eclampsiaand eclampsia Case discussions
Management of Pre-eclampsia and eclampsia Case discussions
 
HYPERTENSIVE DISORDERS.pptx
HYPERTENSIVE DISORDERS.pptxHYPERTENSIVE DISORDERS.pptx
HYPERTENSIVE DISORDERS.pptx
 
What's new in_23rd_davidson's
What's new in_23rd_davidson'sWhat's new in_23rd_davidson's
What's new in_23rd_davidson's
 
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptx
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptxNATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptx
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptx
 
Medical disorders in pregnancy
Medical disorders in pregnancyMedical disorders in pregnancy
Medical disorders in pregnancy
 
highriskpregnancy-190711111446 (1).pptx
highriskpregnancy-190711111446 (1).pptxhighriskpregnancy-190711111446 (1).pptx
highriskpregnancy-190711111446 (1).pptx
 
Hypertension in pregnancy
Hypertension in pregnancyHypertension in pregnancy
Hypertension in pregnancy
 
Preeclampsia
PreeclampsiaPreeclampsia
Preeclampsia
 
Hypertension in pregnancy By Dr ahmad
Hypertension in pregnancy By Dr ahmadHypertension in pregnancy By Dr ahmad
Hypertension in pregnancy By Dr ahmad
 
Hypertensive disorders of pregnancy...arundev
Hypertensive disorders of pregnancy...arundevHypertensive disorders of pregnancy...arundev
Hypertensive disorders of pregnancy...arundev
 
Hypertensive disorders during pregnancy pptx
Hypertensive disorders during pregnancy pptxHypertensive disorders during pregnancy pptx
Hypertensive disorders during pregnancy pptx
 
Lecture 16 Hypertensive disorders in pregnancy
Lecture 16 Hypertensive disorders in pregnancyLecture 16 Hypertensive disorders in pregnancy
Lecture 16 Hypertensive disorders in pregnancy
 
Protocol obs-edited
Protocol obs-editedProtocol obs-edited
Protocol obs-edited
 

Recently uploaded

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 

Recently uploaded (20)

𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)#  Jaipur #𝕔ALL #𝕘IRLS𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)#  Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feel
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptxMALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 

4 High risk preganancy and complications of child birth.pptx

  • 1. HIGH RISK PREGNANCY COMPLICATIONS OF CHILDBIRTH DR. MITALI SRIVASTAVA, MBBS, MD, SEXUAL MEDICINE CONSULTANT, SHITAL WOMENS HOSPITAL, AHMEDABAD, the.besharam.doctor
  • 2. HIGH RISK PREGNANCY [HRP]  Refers to pregnancies in which the mother or the fetus has an increased risk of complications compared to uncomplicated pregnancies  Maternal and medical risks increase pregnancy risk and complications during pregnancy and childbirth
  • 3. BAD OBSTETRIC HISTORY  1st or 2nd trimester miscarriages  Still birth  Small weight baby  Fetal anomalies  IUGR- intrauterine growth restriction  Prolonged labor  Massive PPH  IUD- intrauterine death  Recurrent pregnancy loss
  • 5. SEVERE ANEMIA Who is at risk? • Have two closely spaced pregnancies • Are pregnant with more than one baby • Are vomiting frequently due to morning sickness • Don't consume enough iron-rich foods • Have a heavy pre-pregnancy menstrual flow • Have a history of anemia before your pregnancy
  • 6. SEVERE ANEMIA What are the signs and symptoms?  Anemia: • Fatigue • Weakness • Dizziness or lightheadedness • Headache • Pale or yellowish skin • Shortness of breath • Craving or chewing ice (pica)  Severe anemia: • A rapid heartbeat • Low blood pressure • Difficulty concentrating
  • 7. SEVERE ANEMIA Prevention:  Iron RDA (required daily allowance): 30mg/day  Iron rich diet  Iron supplements:  Should be taken with vit C (helps absorption)  Should not be taken with calcium (reduces absorption)  Can cause constipation, gastric disturbances, dark stools
  • 8. SEVERE ANEMIA Treatment:  Iron injections (eg. Revofer, IV iron bolus)  Blood transfusions, Packed cell volume transfusions
  • 9. MULTIPLE PREGNANCY Why is it high risk?  Preterm labor and birth  Gestational hypertension  Anemia  Birth defects  Miscarriage  Postpartum hemorrhage  Twin to twin transfusion syndrome  Lower backache/ disc prolapse
  • 10. PRE-ECLAMPSIA & ECLAMPSIA  Preeclampsia is a pregnancy-specific disorder involving  Widespread endothelial dysfunction and vasospasm  Occurs after 20 weeks of gestation and can present as late as 4-6 weeks postpartum  Clinically defined by new-onset hypertension and proteinuria, with or without severe features  In a previously normotensive patient: >140/90 mmHg, measured atleast twice, 4 hrs apart  Or a one time reading >160/110 mmHg
  • 11. PRE-ECLAMPSIA & ECLAMPSIA  Severe features: • Impaired hepatic function (elevated LFT) • Severe persistent upper quadrant or epigastric pain that does not respond to pharmacotherapy and is not accounted for by alternative diagnoses • Progressive renal insufficiency • (serum creatinine concentration >1.1 mg/dL or a doubling of the serum creatinine concentration in the absence of other renal disease) • New-onset cerebral or visual disturbances • Pulmonary edema • Thrombocytopenia
  • 12. PRE-ECLAMPSIA & ECLAMPSIA Who is at risk? • Nulliparity • Multifetal gestations • Preeclampsia in a previous pregnancy • Chronic hypertension • Pregestational diabetes • Gestational diabetes • Thrombophilia • Systemic Lupus Erythematoses [SLE] • Pre-pregnancy BMI >30 • Antiphospholipid antibody syndrome • Maternal age 35 years or older • Kidney disease • ART: IVF etc
  • 13. PRE-ECLAMPSIA & ECLAMPSIA What are the clinical features? • Headache • Visual disturbances: Blurred, scintillating scotomata • Altered mental status • Blindness: May be cortical [3] or retinal • Dyspnea • Edema: Sudden increase in edema or facial edema • Epigastric or right upper quadrant abdominal pain • Weakness or malaise: May be evidence of hemolytic anemia • Clonus: May indicate an increased risk of convulsions
  • 14. PRE-ECLAMPSIA & ECLAMPSIA  HELLP syndrome  Hemolysis  Elevated liver enzymes  Low platelets
  • 15. PRE-ECLAMPSIA & ECLAMPSIA  Management of Pre-eclampsia & eclampsia:  Delivery is the only cure for preeclampsia  Patients with preeclampsia without severe features induced after 37 weeks  <37 weeks Hospitalized and monitored for development of worsening preeclampsia or complications of preeclampsia  Immature fetus is treated with corticosteroids to accelerate lung maturity in preparation for early delivery
  • 16. PRE-ECLAMPSIA & ECLAMPSIA Management of active seizures:  The basic principles of airway, breathing, and circulation (ABC) should always be followed  Magnesium sulfate is the first-line treatment for primary and recurrent eclamptic seizures  A loading dose of 4-6g is given by infusion pump over 5-10 minutes  Followed by maintenance dose: infusion of 1g/hr maintained for 24 hours after the last seizure
  • 17. PRE-ECLAMPSIA & ECLAMPSIA  Recurrent seizures: Treated with an additional bolus of 2 g or an increase in the infusion rate to 1.5 or 2 g/hr  Prophylactic treatment with magnesium sulfate is indicated for all patients with preeclampsia with severe features  Magnesium sulfate is discontinued 24 hrs after delivery  Lorazepam and phenytoin may be used as second-line agents for refractory seizures
  • 18. PRE-ECLAMPSIA & ECLAMPSIA Acute treatment of severe hypertension in pregnancy  Antihypertensive treatment is recommended for severe hypertension (>160/110 mmHg)  Goal of hypertension treatment: 140/90 mm Hg  Medications used for BP control include the following: • Hydralazine • Labetalol • Nifedipine • Sodium nitroprusside (in severe hypertensive emergency refractory to other medications)
  • 19. PRE-ECLAMPSIA & ECLAMPSIA Fluid management • Diuretics should be avoided • Aggressive volume resuscitation may lead to pulmonary edema • Patients should be fluid restricted when possible, at least until the period of postpartum diuresis • Central venous pressure (CVP) or pulmonary artery pressure monitoring may be indicated in critical cases • A CVP of 5 mm Hg in women with no heart disease indicates sufficient intravascular volume, and maintenance fluids alone are sufficient • Total fluids should generally be limited to 80 mL/hr or 1 mL/kg/hr
  • 20. PRE-ECLAMPSIA & ECLAMPSIA Postpartum management • Many patients will have a brief (up to 6 hours) period of oliguria following delivery • Magnesium sulfate seizure prophylaxis is continued for 24 hours postpartum • LFT and platelet counts must document decreasing values prior to hospital discharge • Elevated BP may be controlled with nifedipine or labetalol postpartum • If discharged with BP medication, reassessment and a BP check should be performed, frequently and followed up with physician for further management • In most cases of preeclampsia, the BP returns to baseline by 12 weeks postpartum • Patients should be carefully monitored for recurrent preeclampsia, which may develop up to 4 weeks postpartum, and for eclampsia that has occurred up to 6 weeks after delivery
  • 21. GESTATIONAL DIABETES  Defined as glucose intolerance of variable degree with onset or first recognition during pregnancy  Infants of mothers with preexisting DM experience  double the risk of serious injury at birth  triple the likelihood of LSCS  quadruple the incidence of NICU admission  GDM: 90% of cases of diabetes mellitus in pregnancy  Pre- existing type 2 diabetes accounts for 8%
  • 22. GESTATIONAL DIABETES  Screening for GDM:  Random blood sugar as a part of routine reports  OGTT by 5th month of pregnancy  Diagnosis:  Fasting blood glucose  Post-prandial blood glucose  HbA1c
  • 23. GESTATIONAL DIABETES  Management:  Diet care  Glyburide & metformin  Insulin  Prenatal obstetric Mx:  Doppler studies  Fetal heart rate and movement  Mx of Neonate:  Frequent blood glucose checks  Early oral feeding
  • 24. ABRUPTIO PLACENTAE/ PLACENTAL ABRUPTION Separation of placenta, partially or totally, from its implantation site, before delivery  Consumptive coagulopathy  Very high risk of IUD  Fluid replacement with 5% hydroxyethyl starch (plasma volume substitute)  LSCS
  • 26. PLACENTA PREVIA Previa: (Latin) ‘before’ the fetus Placental migration
  • 27. PLACENTA PREVIA  Painless bleeding, bouts of frequent bleeding  Dx: USG  Mx:  Tocolytics  Progesterone supplementation  Tranexa  Absolute bed rest  Planned CS  Emergency delivery if bleeding is not controlled
  • 28. PLACENT PREVIA  Especially in acreta spectrum  Incision is placed in the upper segment, above the tentative position of placenta.  Baby delivered first  Placenta is allowed to separate naturally if possible  Uterine artery or internal iliac artery ligation helpful  High risk for hysterectomy, ICU outcome, Blood transfusion
  • 29. CERVICAL INCOMPETENCE  N- wiring/ cervical cerclage  14 to 16 weeks: preventive  Or as detected
  • 30. THREATENED PRETERM LABOR  At risk for preterm delivery (<37 weeks)  Mx aimed towards stopping labor if possible  Or delaying labor till effect of corticosteroids occurs to bring fetal lungs to maturity  If labor progresses, to conduct a safe delivery
  • 31. OTHER CONDITIONS IN HIGH RISK PREGNANCY  Thrombocytopenia or megaloblastic anemia and other bleeding disorders  Thalassemia  History of thrombosis or thrombophilias  History of neurological disease (epilepsy, brain haemorrhage, or tumor)  Malignancy (cervical, ovarian or breast)  Fibroid uterus  Congenital malformations that can survive
  • 32.
  • 33. COMPLICATIONS IN CHILDBIRTH  DYSTOCIA  PROM  PRECIPITATE LABOR  ABNORMAL PRESENTATIONS  UMBILICAL CORD PROLAPSE  PPH  AMNIOTIC FLUID EMBOLISM
  • 34. DYSTOCIA • Difficult, prolonged labor • Abnormally slow labor progress • Non- progression of labor [NPL] • Pathology lies with: • P- power • P- passenger • P- passage
  • 35. PROM- PREMATURE RUPTURE OF MEMBRANES  Membrane rupture at term without spontaneous uterine contractions  Wait for 6 hrs, and if labor still doesn’t start, induction of labor  Prostaglandin E2 gel (Cerviprime)  Oxytocin infusion IV, after labor initiates only  Antibiotic coverage  Increased risk of:  Chorioamnionitis  NICU admission
  • 36. PRECIPITATE LABOR  Abnormal extremely rapid labor and delivery  Expulsion of fetus in <3 hrs from initiation of labor  Less complications if cervix is effaced  Otherwise:  Cervical/ vaginal/ vulval tears/ lacerations  Uterine rupture  Amniotic fluid embolism  PPH  Linked with cocaine abuse  Newborn injury risk
  • 37. ABNORMAL PRESENTATIONS IN VAGINAL DELIVERY Transverse lie External cephalic version
  • 38.
  • 39.
  • 40.
  • 41. UMBILICAL CORD PROLAPSE  Can occur during labor, or be a presenting part  Eventually causes cord compression  Risk factors:  High floating head  Polyhydramnios  Abnormal presentations  Very small baby  Multifetal gestations  Mx: Head up, manual elevation of fetal head, lscs
  • 42. PPH- POST PARTUM HEMORRHAGE
  • 43. PPH- POST PARTUM HEMORRHAGE  Investigation:  Labs: Hb, Hematocrit evaluation to watch for blood loss  USG: To look for retained placental products  Management:  Uterine massage  Fluid replacement  oxytocin  Tranexa  Methergine  Misoprostol etc  Surgical management
  • 44.
  • 45.  Surgical management:  Vaginal and cervical laceration for traumatic PPH  Laprotomy  Uterine rupture  Uterine lacerations  Hematoma  Uterine artery or internal iliac artery ligation  Compression sutures  Uterine packing (removed after 24 hrs)  Cath lab: Angiographic embolization of uterine artery
  • 47. RARE COMPLICATIONS  Uterine inversion  Amniotic fluid embolism  Uterine rupture  Retained placenta  Puerperial sepsis